Syensqo Initiates Strategic Review of its Performance & Care Segment (€2B)
Syensqo announces the initiation of a strategic review of its Performance & Care segment, as part of its commitment to focus on positioning as a pure player in specialty materials and advanced technologies. This move is part of a broader reflection on accelerating growth and enhancing value creation.
Syensqo is committed to evaluating a range of strategic options for the Performance & Care segment, which includes the Novecare and Technology Solutions activities. The stated goal is to maximize long-term value creation for shareholders by refining the portfolio and refocusing on technologies with the highest growth potential.
This direction aligns with the group's intention to become a specialized pure player in specialty materials and advanced technologies, with increased exposure to structurally attractive markets such as aerospace and defense, electronics, healthcare, energy, and advanced mobility applications.
Scope and Details of the Reviewed Segment
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
You're in — subscription confirmed!
Your first edition is on its way. Check your spam folder and add us to your contacts.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
Gratuit · chaque matin
Ne ratez plus rien sur vos actions
La tendance derrière les cours. L'essentiel des valeurs Euronext en quelques minutes.
📈les valeurs en mouvement, sur la durée
🎯les objectifs d'analystes qui évoluent
📰les actualités qui font bouger les cours
tendance · 6 séances
✓ C'est fait, vous êtes inscrit !
Votre première édition arrive bientôt. Pensez à vérifier vos spams.
Une erreur est survenue.
CAC 40 · SBF 120 · données indicatives · aucun conseil en investissement · désinscription à tout moment.
The Performance & Care segment, consisting of the global business units Novecare and Technology Solutions, is a global leader in surface chemistry solutions and specialty mining reagents. It serves markets in personal care, agriculture, coatings, and mining extraction. In 2025, this segment generated a net revenue of €2.0 billion and an underlying EBITDA of €358 million.
The group has not set a precise timetable for this strategic review. There can be no assurance that this process will result in a transaction, nor on the terms or structure of any potential operation.
Au premier trimestre, nous avons tenu notre cap dans un environnement externe dynamique.
Les ventes nettes ont augmenté de 5%, soutenues par des volumes plus élevés.
Risks mentioned
Le conflit en cours au Moyen-Orient demeure une source d'incertitude.
Impact des variations de change sur les ventes.
Opportunities identified
Amélioration des tendances du carnet de commandes au deuxième trimestre.
Soutien de la croissance à long terme par des initiatives en cours.
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
